Neurocrine Biosciences

Encyclopedia : N : NE : NEU : Neurocrine Biosciences

Neurocrine Biosciences NASDAQ: [NBIX] is a biopharmaceutical company founded in 1992 and located in San Diego, California. The company focuses on therapies for neurological and endocrine diseases and disorders.

The company endured a significant setback on May 15, 2006 when the Food and Drug Administration (FDA) denied approval for the 15-milligram dose of Indiplon, a medication to treat insomnia. Neurocrine had developed the drug with its former partner, Pfizer.

From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.